Hadassah

Hadassah to Conduct Clinical Trial of Israeli-Made COVID-19 Vaccine

Wednesday, Sep 16 2020

The Hadassah Medical Organization is slated to begin a clinical trial with an Israeli-made COVID-19 vaccine in October. One hundred volunteers are being recruited to participate at Hadassah and Tel Aviv’s Sheba Medical Center.

The vaccine, developed by the Israel Institute for Biological Research (IIBR), was tested successfully on hamsters. IIBR announced in June that hamsters who were given its vaccine and later exposed to the contagion did not contract the coronavirus.

The initial phase of the human trial will test for any major side effects. Should the initial results prove positive, the trials will be expanded to hundreds of volunteers in additional medical centers around the country. Volunteers who receive the vaccine will be paid, and they will remain under medical surveillance for a year.

While the experiment still requires the approval of the Israeli Ministry of Health's Helsinki Committee, which oversees the rights, safety and well-being of participants recruited for medical research, Hadassah and Sheba have already begun preparations to recruit young and healthy volunteers.

IIBR engineered the vaccine by replicating a virus that is not harmful to humans and replacing one of its proteins with the coronavirus spike protein. This protein will trigger production of antibodies to it, preventing the virus from binding to human cells.

The Israel Institute for Biological Research (IIBR), whose director general is Prof. Shmuel C. Shapira, former deputy director general of Hadassah Hospital Ein Kerem, is a governmental research facility specializing in biology, chemistry and environmental sciences. As explained on its website, IIBR was founded in 1952 by a group of scientists from the Israel Defense Forces’ Science Corps and from several academic organizations. Over the years, the Institute has been engaged in research and development to provide Israel with scientific responses to chemical and biological threats.

Related Stories

alt_text

Wednesday, Sep 23 2020

COVID-19 and Your Heart: Hadassah’s Pollin Center Makes the Connection

Dr. Donna Zwas, director of Hadassah’s Linda Joy Pollin Cardiovascular Wellness Center for Women, answers questions about the differences in how COVID-19 affects men and women, and its impact on people with heart conditions.

READ MORE ›
alt_text

Wednesday, Sep 23 2020

Hadassah’s Pollin Center Promotes Health, One Neighborhood at a Time

With a mentoring program tailored to community centers, the Hadassah Medical Organization’s Linda Joy Pollin Cardiovascular Wellness Center for Women is transforming these local spaces into health-promotion settings.

READ MORE ›
alt_text

Tuesday, Sep 15 2020

Where Others Gave Up: Hadassah Liver Specialists Save a Father’s Life

Many doctors predicted that Amir Hazan, a 46-year-old father of two, would live for only two years. First diagnosed in 2011 with cirrhosis of the liver, he experienced a rapid decline in his health about a year ago.

READ MORE ›
alt_text

Tuesday, Sep 15 2020

Hadassah Forging Ties With Medical Professionals As UAE, Bahrain Recognize Israel

Hadassah, The Women’s Zionist Organization of America, Inc. National President Rhoda Smolow released the following statement today following the signing of the Abraham Accords...

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Israel Travel

israeltravel@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More